2021 | Seda

Seda announces £4m investment in new state-of-the-art facilities

Seda named ‘Best CRO’ at OBN Awards 2021

Long Acting Injectables: Model Integrated Approaches for Bioequivalence

Movers and Shakers in BioBusiness 2021

Appointment of Paul Gellert

Bionow – 2021 Oncology Conference

Dissolution testing: Real-world evaluation of UV arch probes

Seda Shortlisted as Finalist for Best CRO

AAPS PharmSci 360: Jake Dickinson presents non-linear IVIVC

Life Science Integrates Presentation with Paul Stott

Seda’s Elen Roberts Accepted onto PIAT Master’s Course

Seda’s cutting-edge Differential Scanning Calorimetry capabilities